264 related articles for article (PubMed ID: 21453532)
21. A novel recombinant vaccinia virus expressing the human norepinephrine transporter retains oncolytic potential and facilitates deep-tissue imaging.
Chen N; Zhang Q; Yu YA; Stritzker J; Brader P; Schirbel A; Samnick S; Serganova I; Blasberg R; Fong Y; Szalay AA
Mol Med; 2009; 15(5-6):144-51. PubMed ID: 19287510
[TBL] [Abstract][Full Text] [Related]
22. Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice.
Hofmann E; Weibel S; Szalay AA
J Transl Med; 2014 Jul; 12():197. PubMed ID: 25030093
[TBL] [Abstract][Full Text] [Related]
23. Effective oncolytic vaccinia therapy for human sarcomas.
He S; Li P; Chen CH; Bakst RL; Chernichenko N; Yu YA; Chen N; Szalay AA; Yu Z; Fong Y; Wong RJ
J Surg Res; 2012 Jun; 175(2):e53-60. PubMed ID: 22341347
[TBL] [Abstract][Full Text] [Related]
24. Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody.
Patil SS; Gentschev I; Adelfinger M; Donat U; Hess M; Weibel S; Nolte I; Frentzen A; Szalay AA
PLoS One; 2012; 7(10):e47472. PubMed ID: 23091626
[TBL] [Abstract][Full Text] [Related]
25. Vaccinia virus-mediated intra-tumoral expression of matrix metalloproteinase 9 enhances oncolysis of PC-3 xenograft tumors.
Schäfer S; Weibel S; Donat U; Zhang Q; Aguilar RJ; Chen NG; Szalay AA
BMC Cancer; 2012 Aug; 12():366. PubMed ID: 22917220
[TBL] [Abstract][Full Text] [Related]
26. Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells.
Wang H; Chen NG; Minev BR; Szalay AA
J Transl Med; 2012 Aug; 10():167. PubMed ID: 22901246
[TBL] [Abstract][Full Text] [Related]
27. Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma.
Pugalenthi A; Mojica K; Ady JW; Johnsen C; Love D; Chen NG; Aguilar RJ; Szalay AA; Fong Y
Cancer Gene Ther; 2015 Dec; 22(12):591-6. PubMed ID: 26584530
[TBL] [Abstract][Full Text] [Related]
28. Preclinical evaluation of oncolytic vaccinia virus for therapy of canine soft tissue sarcoma.
Gentschev I; Adelfinger M; Josupeit R; Rudolph S; Ehrig K; Donat U; Weibel S; Chen NG; Yu YA; Zhang Q; Heisig M; Thamm D; Stritzker J; Macneill A; Szalay AA
PLoS One; 2012; 7(5):e37239. PubMed ID: 22615950
[TBL] [Abstract][Full Text] [Related]
29. Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.
Zhang Q; Yu YA; Wang E; Chen N; Danner RL; Munson PJ; Marincola FM; Szalay AA
Cancer Res; 2007 Oct; 67(20):10038-46. PubMed ID: 17942938
[TBL] [Abstract][Full Text] [Related]
30. SPECT/CT imaging of hNIS-expression after intravenous delivery of an oncolytic adenovirus and 131I.
Rajecki M; Sarparanta M; Hakkarainen T; Tenhunen M; Diaconu I; Kuhmonen V; Kairemo K; Kanerva A; Airaksinen AJ; Hemminki A
PLoS One; 2012; 7(3):e32871. PubMed ID: 22412937
[TBL] [Abstract][Full Text] [Related]
31. Molecular network, pathway, and functional analysis of time-dependent gene changes associated with pancreatic cancer susceptibility to oncolytic vaccinia virotherapy.
Haddad D; Socci N; Chen CH; Chen NG; Zhang Q; Carpenter SG; Mittra A; Szalay AA; Fong Y
Mol Ther Oncolytics; 2016; 3():16008. PubMed ID: 27119120
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a new recombinant oncolytic vaccinia virus strain GLV-5b451 for feline mammary carcinoma therapy.
Adelfinger M; Gentschev I; Grimm de Guibert J; Weibel S; Langbein-Laugwitz J; Härtl B; Murua Escobar H; Nolte I; Chen NG; Aguilar RJ; Yu YA; Zhang Q; Frentzen A; Szalay AA
PLoS One; 2014; 9(8):e104337. PubMed ID: 25093734
[TBL] [Abstract][Full Text] [Related]
33. Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68.
Ascierto ML; Worschech A; Yu Z; Adams S; Reinboth J; Chen NG; Pos Z; Roychoudhuri R; Di Pasquale G; Bedognetti D; Uccellini L; Rossano F; Ascierto PA; Stroncek DF; Restifo NP; Wang E; Szalay AA; Marincola FM
BMC Cancer; 2011 Oct; 11():451. PubMed ID: 22011439
[TBL] [Abstract][Full Text] [Related]
34. Effect of increased viral replication and infectivity enhancement on radioiodide uptake and oncolytic activity of adenovirus vectors expressing the sodium iodide symporter.
Oneal MJ; Trujillo MA; Davydova J; McDonough S; Yamamoto M; Morris JC
Cancer Gene Ther; 2013 Mar; 20(3):195-200. PubMed ID: 23412431
[TBL] [Abstract][Full Text] [Related]
35. Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-α signaling.
Kyula JN; Khan AA; Mansfield D; Karapanagiotou EM; McLaughlin M; Roulstone V; Zaidi S; Pencavel T; Touchefeu Y; Seth R; Chen NG; Yu YA; Zhang Q; Melcher AA; Vile RG; Pandha HS; Ajaz M; Szalay AA; Harrington KJ
Oncogene; 2014 Mar; 33(13):1700-12. PubMed ID: 23624923
[TBL] [Abstract][Full Text] [Related]
36. Oncolytic vaccinia therapy of squamous cell carcinoma.
Yu Z; Li S; Brader P; Chen N; Yu YA; Zhang Q; Szalay AA; Fong Y; Wong RJ
Mol Cancer; 2009 Jul; 8():45. PubMed ID: 19580655
[TBL] [Abstract][Full Text] [Related]
37. A novel vaccinia virus with dual oncolytic and anti-angiogenic therapeutic effects against triple-negative breast cancer.
Gholami S; Marano A; Chen NG; Aguilar RJ; Frentzen A; Chen CH; Lou E; Fujisawa S; Eveno C; Belin L; Zanzonico P; Szalay A; Fong Y
Breast Cancer Res Treat; 2014 Dec; 148(3):489-99. PubMed ID: 25391896
[TBL] [Abstract][Full Text] [Related]
38. Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent.
Gentschev I; Stritzker J; Hofmann E; Weibel S; Yu YA; Chen N; Zhang Q; Bullerdiek J; Nolte I; Szalay AA
Cancer Gene Ther; 2009 Apr; 16(4):320-8. PubMed ID: 18949014
[TBL] [Abstract][Full Text] [Related]
39. Targeted radiotherapy for prostate cancer with an oncolytic adenovirus coding for human sodium iodide symporter.
Hakkarainen T; Rajecki M; Sarparanta M; Tenhunen M; Airaksinen AJ; Desmond RA; Kairemo K; Hemminki A
Clin Cancer Res; 2009 Sep; 15(17):5396-403. PubMed ID: 19706820
[TBL] [Abstract][Full Text] [Related]
40. Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma.
Kelly KJ; Woo Y; Brader P; Yu Z; Riedl C; Lin SF; Chen N; Yu YA; Rusch VW; Szalay AA; Fong Y
Hum Gene Ther; 2008 Aug; 19(8):774-82. PubMed ID: 18754710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
